How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?
- PMID: 22253461
- DOI: 10.1200/JCO.2011.39.4577
How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?
Comment on
-
Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus.J Clin Oncol. 2011 Sep 10;29(26):e727-30. doi: 10.1200/JCO.2011.36.2095. Epub 2011 Aug 15. J Clin Oncol. 2011. PMID: 21844496 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
